Clinical trials: Post-Schizophrenic Depression
Post-Schizophrenic Depression
Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
Post-Schizophrenic Depression (PSD) increases the morbidity and mortality of Schizophrenic patients. Hence, it warrants early assessment and intervention. But, clinical trials on PSD are very few.
- Trial name
- PSD-AOFC (NCT04876521)
- Testing
- Amisulpride, Olanzapine-Fluoxetine Combination
- Where
- India
- Volunteers
- 60 people
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar